The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2018 | Lessons in lymphoma: highlights in the field of NHL
John Leonard, MD, from Weill Cornell Medical College, New York City, NY, gives his insight into the key highlights from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, regarding non-Hodgkin lymphoma. Prof. Leonard discusses the clinical trials looking to maximize efficacy whilst reducing toxicity, offering an improved treatment landscape for patients.
